Medicus Pharma Ltd. — Director's Dealing 2024

Dec 31, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31

Reporting Person: Lavelle Frank W (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value ("Common Shares")	25622	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.81	2028-10-24	Common Shares (25000)		Direct

Footnotes

F1: The option has vested and is exercisable as of the date hereof.

F2: Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.